The HTLV-1 hbz antisense gene indirectly promotes tax expression via down-regulation of p30II mRNA

Virology

Volumn 410, Issue 2, 2011, Pages 307-315

  Choudhary, Gunjan ^a   Ratner, Lee ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antisense; Hbz; HTLV 1; P30II; Tax

Indexed keywords

LEUCINE ZIPPER PROTEIN; PROTEIN P30; PROTEIN P30 II; TAX PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE CONSTRUCT; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENETIC COMPLEMENTATION; HETEROLOGOUS EXPRESSION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; MOLECULAR CLONING; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; RNA SPLICING; VIRUS CELL INTERACTION;

BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CELL LINE; GENE EXPRESSION REGULATION, VIRAL; GENE KNOCKOUT TECHNIQUES; GENE PRODUCTS, TAX; GENETIC COMPLEMENTATION TEST; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; PROVIRUSES; RETROVIRIDAE PROTEINS; RNA, MESSENGER; RNA, VIRAL; TRANSCRIPTION, GENETIC; VIRAL PROTEINS;

HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 78751701908     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.11.019     Document Type: Article

References (40)

1. Albrecht B., Lairmore M.D. Critical role of human T-lymphotropic virus type 1 accessory proteins in viral replication and pathogenesis. Microbiol. Mol. Biol. Rev. 2002, 66(3):396-406.
2. Arnold J., Yamamoto B., Li M., Phipps A.J., Younis I., Lairmore M.D., Green P.L. Enhancement of infectivity and persistence in vivo by HBZ, a natural antisense coded protein of HTLV-1. Blood 2006, 107(10):3976-3982.
3. Arnold J., Zimmerman B., Li M., Lairmore M.D., Green P.L. Human T-cell leukemia virus type-1 antisense-encoded gene, Hbz, promotes T-lymphocyte proliferation. Blood 2008, 112(9):3788-3797.
4. Basbous J., Arpin C., Gaudray G., Piechaczyk M., Devaux C., Mesnard J.M. The HBZ factor of human T-cell leukemia virus type I dimerizes with transcription factors JunB and c-Jun and modulates their transcriptional activity. J. Biol. Chem. 2003, 278(44):43620-43627.
5. Boxus M., Willems L. Mechanisms of HTLV-1 persistence and transformation. Br. J. Cancer 2009, 101(9):1497-1501.
6. Cavanagh M.H., Landry S., Audet B., Arpin-Andre C., Hivin P., Pare M.E., Thete J., Wattel E., Marriott S.J., Mesnard J.M., Barbeau B. HTLV-I antisense transcripts initiating in the 3'LTR are alternatively spliced and polyadenylated. Retrovirology 2006, 3:15.
7. Ching Y.P., Chun A.C., Chin K.T., Zhang Z.Q., Jeang K.T., Jin D.Y. Specific TATAA and bZIP requirements suggest that HTLV-I Tax has transcriptional activity subsequent to the assembly of an initiation complex. Retrovirology 2004, 1:18.
8. Clerc I., Hivin P., Rubbo P.A., Lemasson I., Barbeau B., Mesnard J.M. Propensity for HBZ-SP1 isoform of HTLV-I to inhibit c-Jun activity correlates with sequestration of c-Jun into nuclear bodies rather than inhibition of its DNA-binding activity. Virology 2009, 391(2):195-202.
9. Collins N.D., Newbound G.C., Albrecht B., Beard J.L., Ratner L., Lairmore M.D. Selective ablation of human T-cell lymphotropic virus type 1 p12I reduces viral infectivity in vivo. Blood 1998, 91(12):4701-4707.
10. Felber B.K., Paskalis H., Kleinman-Ewing C., Wong-Staal F., Pavlakis G.N. The pX protein of HTLV-I is a transcriptional activator of its long terminal repeats. Science 1985, 229(4714):675-679.
11. Fujii M., Sassone-Corsi P., Verma I.M. c-fos promoter trans-activation by the tax1 protein of human T-cell leukemia virus type I. Proc. Natl Acad. Sci. USA 1988, 85(22):8526-8530.
12. Fujii M., Niki T., Mori T., Matsuda T., Matsui M., Nomura N., Seiki M. HTLV-1 Tax induces expression of various immediate early serum responsive genes. Oncogene 1991, 6(6):1023-1029.
13. Gaudray G., Gachon F., Basbous J., Biard-Piechaczyk M., Devaux C., Mesnard J.M. The complementary strand of the human T-cell leukemia virus type 1 RNA genome encodes a bZIP transcription factor that down-regulates viral transcription. J. Virol. 2002, 76(24):12813-12822.
14. Greger I.H., Demarchi F., Giacca M., Proudfoot N.J. Transcriptional interference perturbs the binding of Sp1 to the HIV-1 promoter. Nucleic Acids Res. 1998, 26(5):1294-1301.
15. Higuchi R., Krummel B., Saiki R.K. A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions. Nucleic Acids Res. 1988, 16(15):7351-7367.
16. Hinuma Y., Nagata K., Hanaoka M., Nakai M., Matsumoto T., Kinoshita K.I., Shirakawa S., Miyoshi I. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc. Natl Acad. Sci. USA 1981, 78(10):6476-6480.
17. Hiraragi H., Kim S.J., Phipps A.J., Silic-Benussi M., Ciminale V., Ratner L., Green P.L., Lairmore M.D. Human T-lymphotropic virus type 1 mitochondrion-localizing protein p13(II) is required for viral infectivity in vivo. J. Virol. 2006, 80(7):3469-3476.
18. Hivin P., Basbous J., Raymond F., Henaff D., Arpin-Andre C., Robert-Hebmann V., Barbeau B., Mesnard J.M. The HBZ-SP1 isoform of human T-cell leukemia virus type I represses JunB activity by sequestration into nuclear bodies. Retrovirology 2007, 4:14.
19. Hooper W.C., Rudolph D.L., Lairmore M.D., Lal R.B. Constitutive expression of c-jun and jun-B in cell lines infected with human T-lymphotropic virus types I and II. Biochem. Biophys. Res. Commun. 1991, 181(3):976-980.
20. Kimata J.T., Wong F.H., Wang J.J., Ratner L. Construction and characterization of infectious human T-cell leukemia virus type 1 molecular clones. Virology 1994, 204(2):656-664.
21. Langton B.C., Sliwkowski M., Tran K.V., Knapp S., Keitelman E., Smith C., Wallingford S., Liu H.-L., Ralston J.S., Brandis J., Coates S. Development and characterization of monoclonal antibodies to the HTLV-I Tax (P40X) protein. Med. Virol. 1988, 8:295.
22. Larocca D., Chao L.A., Seto M.H., Brunck T.K. Human T-cell leukemia virus minus strand transcription in infected T-cells. Biochem. Biophys. Res. Commun. 1989, 163(2):1006-1013.
23. Lemasson I., Lewis M.R., Polakowski N., Hivin P., Cavanagh M.H., Thebault S., Barbeau B., Nyborg J.K., Mesnard J.M. Human T-cell leukemia virus type 1 (HTLV-1) bZIP protein interacts with the cellular transcription factor CREB to inhibit HTLV-1 transcription. J. Virol. 2007, 81(4):1543-1553.
24. Matsumoto J., Ohshima T., Isono O., Shimotohno K. HTLV-1 HBZ suppresses AP-1 activity by impairing both the DNA-binding ability and the stability of c-Jun protein. Oncogene 2005, 24(6):1001-1010.
25. Matsuoka M., Green P.L. The HBZ gene, a key player in HTLV-1 pathogenesis. Retrovirology 2009, 6:71.
26. Matsuoka M., Jeang K.T. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat. Rev. Cancer 2007, 7(4):270-280.
27. Murata K., Hayashibara T., Sugahara K., Uemura A., Yamaguchi T., Harasawa H., Hasegawa H., Tsuruda K., Okazaki T., Koji T., Miyanishi T., Yamada Y., Kamihira S. A novel alternative splicing isoform of human T-cell leukemia virus type 1 bZIP factor (HBZ-SI) targets distinct subnuclear localization. J. Virol. 2006, 80(5):2495-2505.
28. Nicot C., Dundr M., Johnson J.M., Fullen J.R., Alonzo N., Fukumoto R., Princler G.L., Derse D., Misteli T., Franchini G. HTLV-1-encoded p30II is a post-transcriptional negative regulator of viral replication. Nat. Med. 2004, 10(2):197-201.
29. Palmer A.C., Ahlgren-Berg A., Egan J.B., Dodd I.B., Shearwin K.E. Potent transcriptional interference by pausing of RNA polymerases over a downstream promoter. Mol. Cell 2009, 34(5):545-555.
30. Peloponese J.M., Kinjo T., Jeang K.T. Human T-cell leukemia virus type 1 Tax and cellular transformation. Int. J. Hematol. 2007, 86(2):101-106.
31. Poiesz B.J., Ruscetti F.W., Gazdar A.F., Bunn P.A., Minna J.D., Gallo R.C. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl Acad. Sci. USA 1980, 77(12):7415-7419.
32. Rauch D., Gross S., Harding J., Niewiesk S., Lairmore M., Piwnica-Worms D., Ratner L. Imaging spontaneous tumorigenesis: inflammation precedes development of peripheral NK tumors. Blood 2009, 113(7):1493-1500.
33. Robek M.D., Ratner L. Immortalization of CD4(+) and CD8(+) T lymphocytes by human T-cell leukemia virus type 1 Tax mutants expressed in a functional molecular clone. J. Virol. 1999, 73(6):4856-4865.
34. Satou Y., Yasunaga J., Yoshida M., Matsuoka M. HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells. Proc. Natl Acad. Sci. USA 2006, 103(3):720-725.
35. Silverman L.R., Phipps A.J., Montgomery A., Ratner L., Lairmore M.D. Human T-cell lymphotropic virus type 1 open reading frame II-encoded p30II is required for in vivo replication: evidence of in vivo reversion. J. Virol. 2004, 78(8):3837-3845.
36. Smith M.R., Greene W.C. Identification of HTLV-I tax trans-activator mutants exhibiting novel transcriptional phenotypes. Genes Dev. 1990, 4(11):1875-1885.
37. Usui T., Yanagihara K., Tsukasaki K., Murata K., Hasegawa H., Yamada Y., Kamihira S. Characteristic expression of HTLV-1 basic zipper factor (HBZ) transcripts in HTLV-1 provirus-positive cells. Retrovirology 2008, 5:34.
38. Ye J., Silverman L., Lairmore M.D., Green P.L. HTLV-1 Rex is required for viral spread and persistence in vivo but is dispensable for cellular immortalization in vitro. Blood 2003, 102(12):3963-3969.
39. Yin M.J., Gaynor R.B. Complex formation between CREB and Tax enhances the binding affinity of CREB for the human T-cell leukemia virus type 1 21-base-pair repeats. Mol. Cell. Biol. 1996, 16(6):3156-3168.
40. Yoshida M., Satou Y., Yasunaga J., Fujisawa J., Matsuoka M. Transcriptional control of spliced and unspliced human T-cell leukemia virus type 1 bZIP factor (HBZ) gene. J. Virol. 2008, 82(19):9359-9368.